SOLID LIPID NANOPARTICLE DEVELOPMENT FORMULATION TRANSDERMAL DOSAGE FORM OF FUROSEMIDE AND IN VITRO TESTING
Background: Furosemide is a potent diuretic agent with a half life 45-60 minutes and oral bioavailability about of 50%. Transdermal dosage form is used to improve bioavalability of furosemide, but stratum corneum acts as barrierfor penetration furosemide pass through the skin. To overcome this pr...
Saved in:
Main Author: | Forestryana, Dyera |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/44436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
FORMULATION OF FUROSEMIDE SOLID LIPID NANOPARTICLES AND IN VITRO RELEASE STUDY
by: Dang Huei Huei, Adeline -
FORMULATION, CHARACTERIZATION, AND IN VITRO TOXICITY TEST OF LIPID NANOPARTICLE DOSAGE FORM FOR SIMVASTATIN DRUG DELIVERY
by: Ricardo Setiadi, Anfield -
Effects of transdermal dosage forms on IN VITRO pig skin permeation of glucosamine hydrochloride
by: Punlapa Anusitthakul
Published: (2014) -
FORMULATION AND ANTIMALARIAL ACTIVITY TEST OF ARTEMETHER CONTAINED IN SOLID LIPID NANOPARTICLES (SLN) IN VITRO AND IN VIVO
by: Febyuli Ulya, Shella -
Preformulasi Sediaan Furoseivhda Mudah Larut: A Preformulation of a Water Soluble Furosemide Dosage Form
by: Perpustakaan UGM, i-lib
Published: (2002)